Construction of an in vitro lymphoid organoid: studying innate-adaptive immune cell interaction in a 3D culture system
Construction of an in vitro lymphoid organoid: studying innate-adaptive immune cell interaction in a 3D culture system
批准号:
BB/F001142/1
负责人:
Amir Ghaemmaghami
金额:
$43.29万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2007
资助国家:
英国
项目状态:
已结题
起止时间:
2007 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The immune system is made up of two components, innate and adaptive. Innate immune cells, mainly dendritic cells, fight pathogens using defences that are quickly mobilised and triggered by cell surface molecules (receptors) that recognise a broad spectrum of pathogens. Adaptive immune cells, such as T cells, on the other hand provide a more specific and long-term protection against pathogens. Although the classification of immunity into innate and adaptive has served to simplify and facilitate the description of many immunological events, it is becoming increasingly evident that the interaction between innate and adaptive immune cells is crucial for mounting appropriate immune responses. This, therefore, necessitated the establishment of suitable culture systems and animal models for studying such interactions, and the use of these systems has so far been useful in understanding the interrelationships between dendritic cells and T cells. However, in trying to better recreate what happens in the human lymph nodes (the small organs where dendritic cells and T cells meet), we are proposing to construct a three-dimensional culture system that resembles a lymphoid organoid. This will hopefully be a more physiological system and one that will allow the development of further applications for studying cell-cell interactions. If successful, this system will eventually reduce the number of some animal experimentations. The development of such a system is timely given that the 7th amendment to the EU Cosmetics Directive will impose a marketing ban on new ingredients tested on animals from 2009 onwards. Our initiative is supported by Unilever, a company which has considerable experience and vested interest in the development of model systems for predicting the allergenic potential of new healthcare products.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.polymer.2013.09.041
发表时间:
2014-01
期刊:
Polymer
影响因子:
4.6
作者:
[Y. Reinwald;R. Johal;A. Ghaemmaghami;F. Rose;S. Howdle;K. Shakesheff]
通讯作者:
Y. Reinwald;R. Johal;A. Ghaemmaghami;F. Rose;S. Howdle;K. Shakesheff
DOI:
10.1371/journal.pone.0010123
发表时间:
2010-04-19
期刊:
PloS one
影响因子:
3.7
作者:
[García-Nieto S, Johal RK, Shakesheff KM, Emara M, Royer PJ, Chau DY, Shakib F, Ghaemmaghami AM]
通讯作者:
Ghaemmaghami AM
Cellular in Vitro Testing: Methods and Protocols
细胞体外测试:方法和方案
DOI:
--
发表时间:
2014
期刊:
影响因子:
--
作者:
[Haycock, John W., Ahluwalia, Arti, Wilkinson, J. Malcolm]
通讯作者:
Wilkinson, J. Malcolm
An iPSC based xeno-free platform to assess the foreign body response against new biomaterials
-
批准号:NC/Y000838/1
-
项目类别:Research Grant
-
资助金额:$76.31万
-
财政年份:2024
-
负责人:Amir Ghaemmaghami
-
依托单位:
Using microscale technologies in tissue engineering of human lung
-
批准号:BB/I02643X/1
-
项目类别:Research Grant
-
资助金额:$0.63万
-
财政年份:2011
-
负责人:Amir Ghaemmaghami
-
依托单位:
Construction of an immuno-competent and self reporting human lung model using nanosensor incorporated scaffolds
-
批准号:BB/H011293/1
-
项目类别:Research Grant
-
资助金额:$48.52万
-
财政年份:2010
-
负责人:Amir Ghaemmaghami
-
依托单位:
国内基金
海外基金
登录
查看更多内容
体外流体环境下内皮和平滑肌细胞共培养与细胞行为的研究
-
批准号:32070799
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:丁永胜
-
依托单位:
基于滋养层类器官探究早期胎盘发育
-
批准号:31900572
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:马启旺
-
依托单位:
基于BYL in vitro体系的抗病毒生物药剂分子作用机理研究
-
批准号:31401710
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2014
-
负责人:安梦楠
-
依托单位:
基于In vitro细胞模型的饲料虾青素的吸收、转运、沉积机制及作用机理研究
-
批准号:31101911
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2011
-
负责人:牛津
-
依托单位:
In silico/In vitro偶联ACAT生理模型筛选药物及其制剂的生物利用度/生物等效性
-
批准号:81173009
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2011
-
负责人:孙进
-
依托单位:
丙型肝炎病毒感染宿主细胞的分子生物学研究
-
批准号:30870127
-
项目类别:面上项目
-
资助金额:40.0万元
-
批准年份:2008
-
负责人:钟劲
-
依托单位: